Skip to main content

Table 3 Comparison of consumption in DDD-10,000 inhabitants in the three Brazilian cities studied

From: Essential psychiatric medicines: wrong selection, high consumption and social problems

ATC code Generic names Presence in WHO/RENAME and/or RESME City 1 City 2 City 3 Mean + Std Dev(%)
2009 2010 2010
  Antidepressants Total - 242.6 229.9 253.7 242.1 ± 11.9 (100 %)
N06AA Tricyclic Antidepressants - 40.3 37.4 35.6 37.7 ± 2.3 (15.5)
N06AA09 amitriptyline Y 21.0 25.9 26.5 24.4 ± 3.0 (10.1)
N06AA04 clomipramine Y 5.2 5.9 3.8 4.9 ± 1.1 (2.0)
N06AA10 nortriptyline Y 0.6 2.3 1.6 1.5 ± 0.8 (0.6)
N06AA02 imipramine N 13.5 3.1 3.6 6.7 ± 5.8 (2.7)
N06AB SSRI Antidepressants a - 202.3 192.5 218.1 204.3 ± 12.9 (84.3)
N06AB03 fluoxetine Y 152.9 136.1 161.1 150.0 ± 12.7 (61.9)
N06AB06 sertraline N 49.3 56.4 56.9 54.2 ± 4.2 (22.4)
N06AB04 citalopram N 0.1 NA NA -
N06AX Other Antidepressants   1.9 - - -
N06AX12 bupropion Y 1.9 NA NA -
N03AE/ N05BA/N05CD Benzodiazepines Total - 161.9 117.1 98.1 125.7 ± 32.7 (100 %)
N05CD08 midazolam Y NA 0.004 NA -
N05CD02 nitrazepam N 31.3 11.3 11.7 18.1 ± 11.4 (14.4)
N03AE01 clonazepam Y 11.1 19.5 28.8 19.8 ± 8.8 (15.7)
N05BA09 clobazam N 1.4 NA NA -
N05BA01 diazepam Y 118.1 86.3 57.6 87.3 ± 30.2 (69.4)
  1. Y yes, the medicine is present on the list, N no, the medicine is not present on the list, NA not available
  2. aSSRI antidepressants selective serotonin reuptake inhibitor antidepressants